{
    "2020-01-17": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Pharma and Biotech Aren’t Worried About Democratic Candidates’ Attacks Against Drugmakers",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Biotech",
                        "Democratic",
                        "Candidates",
                        "Attacks",
                        "Drugmakers"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Ozempic",
                        "FDA",
                        "Nod",
                        "CV Risk",
                        "Reduction"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Why Amarin Stock Is Poised for a Healthy 2020",
                "features": {
                    "keywords": [
                        "Amarin",
                        "Stock",
                        "Poised",
                        "Healthy",
                        "2020"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}